Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Tolerability of Varenicline When Used for Smoking Cessation/Reduction in Individuals With Severe and Persistent Mental Illness: An Open Label Pilot Trial

NCT00702793 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT00702793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00702793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Tolerability of Varenicline When Used for Smoking Cessation/Reduction in Individuals With Severe and Persistent Mental Illness: An Open Label Pilot Trial
Lead sponsor
University of British Columbia
Phase
Phase 4
Overall status
Withdrawn
Start date
April 30, 2008
Completion date
May 31, 2012
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

psychosis, schizoaffective, schizophrenia